Cargando…

Blockade of IL-6/IL-6R Signaling Attenuates Acute Antibody-Mediated Rejection in a Mouse Cardiac Transplantation Model

Acute antibody-mediated rejection (AAMR) is an important cause of cardiac allograft dysfunction, and more effective strategies need to be explored to improve allograft prognosis. Interleukin (IL)-6/IL-6R signaling plays a key role in the activation of immune cells including B cells, T cells and macr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Maolin, Sun, Qipeng, Li, Xiujie, Deng, Gengguo, Zhang, Yannan, Yang, Zhe, Han, Fei, Huang, Zhengyu, Fang, Youqiang, Liao, Tao, Sun, Qiquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581398/ https://www.ncbi.nlm.nih.gov/pubmed/34777394 http://dx.doi.org/10.3389/fimmu.2021.778359

Ejemplares similares

Corrigendum: Blockade of IL-6/IL-6R Signaling Attenuates Acute Antibody-Mediated Rejection in a Mouse Cardiac Transplantation Model
por: Ma, Maolin, et al.
Publicado: (2021)

Artemisinin Attenuates Transplant Rejection by Inhibiting Multiple Lymphocytes and Prolongs Cardiac Allograft Survival
por: Yang, Zhe, et al.
Publicado: (2021)

Triptolide Attenuates Transplant Vasculopathy Through Multiple Pathways
por: Luo, Zihuan, et al.
Publicado: (2020)

Ex vivo anchored PD‐L1 functionally prevent in vivo renal allograft rejection
por: Luo, Zihuan, et al.
Publicado: (2022)

Donor plasma mitochondrial DNA is associated with antibody-mediated rejection in renal allograft recipients
por: Han, Fei, et al.
Publicado: (2021)

Noninvasive and quantitative measurement of C4d deposition for the diagnosis of antibody-mediated cardiac allograft rejection
por: Liao, Tao, et al.
Publicado: (2018)

Preventative effect of TSPO ligands on mixed antibody-mediated rejection through a Mitochondria-mediated metabolic disorder
por: Zhang, Yannan, et al.
Publicado: (2023)

The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey
por: Jeyaratnam, Jerold, et al.
Publicado: (2018)

Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection
por: Zhao, Daqiang, et al.
Publicado: (2018)

Plasma Macrophage Migration Inhibitory Factor Predicts Graft Function Following Kidney Transplantation: A Prospective Cohort Study
por: Ye, Yongrong, et al.
Publicado: (2021)

Blockade of IL‐33 signalling attenuates osteoarthritis
por: He, Zengliang, et al.
Publicado: (2020)

Outlook of IL-6 signaling blockade for COVID-19 pneumonia
por: Hashizume, Misato
Publicado: (2020)

Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial
por: Sun, Qipeng, et al.
Publicado: (2017)

IL-6 Directed Therapy in Transplantation
por: Miller, Cynthia L., et al.
Publicado: (2021)

Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood–Retinal Barrier Integrity In Vitro
por: Mesquida, Marina, et al.
Publicado: (2019)

IL‐6 receptor blockade for allograft dysfunction after lung transplantation in a patient with COPA syndrome
por: Riddell, Peter, et al.
Publicado: (2021)

IL-6 Blockade as a Therapeutic Approach for Duchenne Muscular Dystrophy
por: Mammen, Andrew L., et al.
Publicado: (2015)

Demystifying MOGAD and Double Seronegative NMOSD Further With IL-6 Blockade
por: Yong, Kok Pin, et al.
Publicado: (2021)

BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19(high) B lymphocytes
por: Chen, Yu-Li, et al.
Publicado: (2019)

In Vivo Attenuation of Antibody-Mediated Acute Renal Allograft Rejection by Ex Vivo TGF-β-Induced CD4(+)Foxp3(+) Regulatory T Cells
por: Liao, Tao, et al.
Publicado: (2017)

IL-21 Biased Alemtuzumab Induced Chronic Antibody-Mediated Rejection Is Reversed by LFA-1 Costimulation Blockade
por: Kwun, Jean, et al.
Publicado: (2018)

Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
por: vom Berg, Johannes, et al.
Publicado: (2013)

Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population
por: Rodrigues, Fabíola Brasil Barbosa, et al.
Publicado: (2023)

Ribonucleic acid interference knockdown of IL-6 enhances the efficacy of cisplatin in laryngeal cancer stem cells by down-regulating the IL-6/STAT3/HIF1 pathway
por: Fu, Qiang, et al.
Publicado: (2017)

IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells
por: Hsieh, Wan-Chen, et al.
Publicado: (2018)

IL-6 blockade for COVID-19: a global scientific call to arms
por: Murthy, Srinivas, et al.
Publicado: (2021)

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration
por: Zhou, Yifan, et al.
Publicado: (2022)

Blockade of IL-6R prevents preterm birth and adverse neonatal outcomes
por: Farias-Jofre, Marcelo, et al.
Publicado: (2023)

Blockade of IL-6 signaling prevents paclitaxel-induced neuropathy in C57Bl/6 mice
por: Huehnchen, Petra, et al.
Publicado: (2020)

Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma
por: Sgherza, Nicola, et al.
Publicado: (2021)

IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
por: Rose-John, Stefan
Publicado: (2012)

Attenuation of relapsing fever neuroborreliosis in mice by IL-17A blockade
por: Cheng, Meihui, et al.
Publicado: (2022)

Classical Signaling and Trans-Signaling Pathways Stimulated by Megalobrama amblycephala IL-6 and IL-6R
por: Wang, Jixiu, et al.
Publicado: (2022)

Acetyl salicylic acid inhibits Th17 airway inflammation via blockade of IL-6 and IL-17 positive feedback
por: Moon, Hyung-Geun, et al.
Publicado: (2013)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

The importance of IL-6 blockade beyond the COVID-19 pandemic: Consideration for cancer care()
por: Iorio, Giuseppe Carlo, et al.
Publicado: (2020)

8. An autoinflammatory syndrome resembling Castleman’s disease with excellent response to IL-6 blockade
por: Chakravorty, Mithun, et al.
Publicado: (2019)

IL6/IL6R genetic diversity and plasma IL6 levels in bipolar disorder: An Indo-French study
por: Sundaresh, Aparna, et al.
Publicado: (2019)

IL-6 Quotient (The Ratio of Cerebrospinal Fluid IL-6 to Serum IL-6) as a Biomarker of an Unruptured Intracranial Aneurysm
por: Kamińska, Joanna, et al.
Publicado: (2021)

Dissecting the IL‐6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R
por: Cupido, Arjen J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0p51pdh0ru53hg3dn06ovqjo8i